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Summary 
The major histocompatibility (MHC) class I-b molecule H-2M3 ' binds and presents N-formy- 
lated peptides to cytotoxic T lymphocytes. This requirement potentially places severe constraints 
on the number of peptides that M3" can present to the immune system. Consistent with this 
idea, the M3~-L  a MHC class I chimera is expressed at very low levels on the cell surface,  but 
can be induced significantly by the addition of specific peptides at 27~  Using this assay, we 
show that M3 ~ binds many very short N-formyl peptides, including N-formyl chemotactic pep- 
tides and canonical octapeptides. This observation is in sharp contrast to the paradigmatic size 
range of peptides of 8-10 amino acids binding to most class I-a molecules and the class I-b mole- 
cule Qa-2. Stabilization by fMLF-benzyl amide could be detected at peptide concentrations as 
low as 100 nM. While N-formyl peptides as short as two amino acids in length stabilized expres- 
sion of M3a-L a, increasing the length of these peptides added to the stability of peptide-MHC 
complexes as determined by 27-37~  temperature shift experiments. We propose that relaxation 
of the length rule may represent a compensatory adaptation to maximize the number of peptides 
that can be presented by H-2M3 a. 
M 
ost peptides eluted from MHC class I molecules are 
8-10 amino acids long, depending on the allele (1, 2), 
as confirmed by crystallography of various mouse and human 
class I molecules (3-5). The charged amino and carboxyl pep- 
tide termini engage deep pockets in the antigen-binding cleft 
by forming hydrogen bonds with highly conserved heavy chain 
residues within pocket A (for the NH2 terminus) and pocket 
F  (COOH  terminus).  For H-2K  b,  peptides that  are nine 
amino acids in length buckle at positions P4 and P5 to ac- 
commodate  the  termini  in  these  pockets  (3).  Terminal 
modifications such as N-formylation or C-amidation inhibit 
formation of hydrogen bonds and severely impair binding 
(6, 7). Similarly, heavy chain mutations disrupting H bonding 
in these pockets greatly destabilize the MHC complex (8). 
However, the length rule of 8-10 amino acids is not abso- 
lute. Longer peptides (14-17 amino acids) bind a minor frac- 
tion of HLA-A2, HLA-B27,  and H-2K  b molecules (9-11), 
and La-restricted peptides as short as four amino acids have 
been reported to be presented to CTL (12, 13). In addition, 
inhibition of some (14) but not all (15) M3~-restricted  CTLs 
by chemotactic peptides has been reported. 
Allele-specific  pockets impart peptide specificity to class 
I molecules. Peptide anchor residues are often located at the 
P2, PS, and COOH terminal residues (1). To bind a partic- 
ular class I-a molecule, peptides must have the correct length 
and appropriate binding motif. This paradigm also applies 
to the class I-b molecule Qa-2 (16,  17). 
The requirement for a fixed NH2 terminus is reiterated 
in  M3  ~,  in  which  replacements  of conserved residues  in 
pocket A may account for the nearly absolute demand for 
the N-formyl moiety (18,  19). The N-formyl terminus of 
NADH dehydrogenase subunit I (fND1) 1 binds M3 a to stim- 
ulate fNDl-specific CTL (18, 19). The natural length of en- 
dogenous N-formyl peptides bound by M3 ~ is not known. 
To quantify cell surface expression of M3 ~,  we have con- 
structed a class I chimera comprised of the otl and o~2 do- 
mains of M3  a and or3 of L a (M3~-L  a) that is detected by the 
L a ot3-specific mAb HB27  (20).  Surface expression of the 
chimera is limited physiologically by the poor availability of 
N-formyl peptide ligands (21). Although the mechanisms differ 
in detail, this phenotype resembles that of surface expression 
of MHC class I molecules in RMA-S cells. These possess defec- 
tive transporters associated  with antigen processing (TAP) 
proteins and consequently fail to transport peptides into the 
endoplasmic reticulum (22).  Addition of specific peptide or 
incubation at cold temperatures (~<31~  restored surface ex- 
pression of class I molecules in these mutant cells (23). Simi- 
larly, addition of appropriate exogenous ligands stabilized sur- 
face expression of M3~-L  a (21). 
By focusing on N-formyl peptides, M3 ~ binds a far nar- 
1  Abbreviations used in this paper: CI, confidence  interval; fND1, N-formyl 
terminus of NADH dehydrogenase  subunit 1; GAMIg, goat anti-mouse 
Ig; IBS, independent  binding of side chains; SMLF, specific  mean linear 
fluorescence; TAP, transporters associated  with antigen processing. 
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molecules.  Its specificity for N-formyl peptides  potentially 
narrows the thymocyte-selecting (self)-repertoire of M3 a to 
a small subset of mitochondrial-encoded peptides. This strin- 
gency of peptide  binding  allows M3 a to  ignore  most  self- 
peptides and focus on bacterial peptides. Since as prokaryotes 
initiate  proteins  with  N-formylmethionine,  M3 a  may  be 
adapted for presenting microbial peptides to CD8 + T  cells 
(24, 25).  Consistent  with this hypothesis,  M3 ~ presents pep- 
tides from Listeria monocytogenes to CD8 § ot~ T  cells (14,  15). 
Infecting bacteria release N-formyl peptides that bind the 
chemotactic peptide receptor on neutrophils and monocytes 
to trigger migration and cytokine release (26). The chemotactic 
peptide receptor recognizes  peptides  of three to  six amino 
acids in length,  shorter  than  typical MHC  class I-binding 
peptides (27). We postulated that to expand the number and 
diversity  of its  bacterial  ligands,  M3 ~ may also  bind  short 
N-formyl peptides, 
Materials and Methods 
Antibodies.  Supernatants  of hybridomas  were  used  for  im- 
munofluorescence, mAbs were specific for the or3 domain of the 
L a molecule, HB27 (American Type Culture Collection [ATCC], 
Rockville,  MD);  a  conformationally  sensitive  epitope  on  K b, 
TIB139 (ATCC);  another conformationally sensitive  epitope on 
K b, HB176 (ATCC; 6);  and a conformationally sensitive epitope 
on D b, HB19 (ATCC; 28).  IgG fractions of culture supernatants 
were separated using a protein G column in an FPLC  TM system (Phar- 
macia Fine Chemicals, Piscataway,  NJ) and used for all immuno- 
precipitations. 
Peptide Synthesis and Purification.  The fND1 peptide corresponds 
to the amino terminus of ND1 ~. The sequence of the dodecameric 
peptide  is  fMFFINILTLLVP, f-Bla-zl.s  peptide  (fMFVLNKFF), 
from Bacillus cereus B-lactamase, binds  to M3 ~ as determined by 
CTL competition assays (24) and M3~-L  a stabilization  (21). Ac-Bla-z 
and Bla-z are the N-acetylated and unsubstituted forms of this pep- 
tide, respectively.  The SIINFEKL peptide refers to a peptide from 
chicken  ovalbumin  that  has been  shown  to bind  K b (29).  The 
Sendai virus nucleocapsid peptide FAPGNYPAL binds both to K b 
and D b (30).  Indicated lengths of these peptides were synthesized 
and HPLC purified as described previously (I9). All other short 
N-formyl peptides were obtained from Sigma Chemical Co. (St. 
Louis, MO) or Bachem Biochemicals (King of Prussia, PA). Sev- 
eral non-N-formylated short peptides (Sigma Chemical Co.) were 
used  as  negative controls.  These include  GILGDSPK,  GGFM, 
GGFL-NH2, AGSE,  GQ, GLM-NH2, and N-carboxymethyl-FL. 
Cytotoxic T Lymphocyte Generation.  The fNDl'~-specific,  M3 ~- 
restricted mCTL  clones 1D8 and 3D5 were described elsewhere 
(18). These mCTLs are specific for a peptide from the mitochon- 
drial gene product ND1 (NADH dehydrogenase subunit 1) in the 
context of M3 ~. 
Cell  Culture.  SVCAS2.F6  tail  cell  fibroblasts  (H-2  w17 M3 b) 
were transfected with pM3~-L  a to create the  13S2 cell  line (21). 
Cells were passaged in DMEM plus 10% FCS, 1% gentamicin re- 
agent solution, and 1 mg/ml G418.  WEHI 105.7 thymoma cells 
were described elsewhere (18). All cell culture reagents were from 
GIBCO BILL (Gaithersburg,  MD). 
Immunofluorescence Staining and Flow Cytometry Analysis.  Im- 
munofluorescence analysis was done as described (21, 31). Briefly, 
subconfluent transfected cells were incubated with the designated 
peptide for 12-16  h at 37 or 270C in culture media. Cells  were 
trypsinized, collected,  and washed three times in ice-cold PBS be- 
fore resuspension in PBS at a final concentration of 107 cells/ml. 
100/ll of cell suspension was incubated with 100/~1 of mAb in 
the appropriate dilution for 30 rain at 40C. After two washes with 
cold PBS,  the cells were stained with a  1:50 dilution  of FITC- 
conjugated goat anti-mouse (GAMIg) antibodies (Baxter Health- 
care Corp., Mundelein, IL) for 30 rain at 40C. Samples were then 
fixed with 1% paraformaldehyde (vol/vol in PBS) and analyzed on 
a flow cytometer (EPICS Profile;  Coulter Corp.,  Hialeah,  FL). 
Specific mean linear fluorescence (SMLF) of a population on a four- 
decade  scale (0.1-1,000)  was calculated by subtracting the mean 
linear fluorescence  of cells stained with FITC-GAMIg alone from 
the mean linear fluorescence of cells stained with a particular mAb. 
Voltages  were adjusted to ensure that control staining with the 
secondary antibody alone (FITC-GAMIg) was ,x,1  _+  0.2 U. Ad- 
ditionally,  gates were set around narrow windows of forward light 
scatter to minimize cell  size-dependent  artifacts (31). 
Peptide Competition Assay.  This assay was described  elsewhere 
(18). WEHI 105.7 cells were washed and resuspended to 6  x  106 
cells/ml in growth medium. 15  x  106 cells were incubated with 
250 mCi of Na2[51Cr]O4 in a 15-ml graduated conical tube (Falcon 
2099; Becton Dickinson & Co., Lincoln Park, NJ) on a rocker plat- 
form at intermediate speed at 37~  for 90 rain. These cells were 
washed once and placed over an isolymph gradient to enrich for 
viable cells. After two washes, cells were incubated in prewarmed 
growth medium at a concentration of 1.33  x  106 cells/ml. 3 ml 
of cells was added to 12-well tissue culture plates  (Costar Corp., 
Cambridge, MA). Increasing concentrations of putative compet- 
itor peptide were dissolved in 1 ml of prewarmed media in the pres- 
ence of 50 nM fND1%12 and added to the cells. The cells were 
incubated  at  37~  in  5%  COz  for  90  rain.  Target  cells  were 
washed twice before incubation with either CTL clone 1D8 or 
3D5 in a 4-h Na2[SlCr]O4 release assay using an E/T ratio of 20:1. 
Percentage of specific lysis was calculated as follows: percent specific 
lysis  =  [(experimental release  -  spontaneous release)/(maximal 
release  -  spontaneous release)]  x  100%. Unless otherwise indi- 
cated, standard errors of the measurements, calculated by propaga- 
tion of errors (32),  were <5%. 
Temperature Shift Assay.  13S2  cells were incubated with the in- 
dicated peptide at 27~  for 16 h. Cells were transferred to 37~ 
for graded periods of time, rapidly placed on ice, and stained using 
the protocol described above.  Fold increase was calculated  as the 
SMLF of cells incubated with peptide divided by the SMLF of cells 
incubated in medium containing DMSO alone.  In some experi- 
ments, cells induced with peptide at 27~  overnight were shifted 
to 37~  without changing the medium to monitor the loss of sur- 
face expression. The rate of loss was estimated by nonlinear regres- 
sion using an approach-to-steady-state model described by the fol- 
lowing equation (33): 
Ct  =  ko  _  (k0  _  Co)*  e -k'' 
kl  ki 
Data were analyzed using an adaptive nonlinear least-squares  al- 
gorithm (34)  in  the program Nonlin (Phillip H. Sherrod, 4410 
Gerald Place,  Nashville,  TN 37205-3806.  76166.2640@compu- 
serve.com).  The program was instructed to minimize the error of 
three parameters: Co, the steady-state  value at 27~  k0, the zero- 
order rate constant of appearance of epitopes at the surface;  and 
kl, the first-order rate constant of loss (where tv2  =  ln2/k 0. Data 
supplied were the time (t) and SMLF (C,) after the return to 37~ 
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I~esu|ts 
N-Formyl NDI Peptides  As Short As Two Amino Acids Stabi- 
lized M3~-L  d Expression on the Cell Surface.  To test the hy- 
pothesis that M3 a might bind very short peptides, a series 
of  N-formyl  peptides  corresponding  to  truncated  NH2- 
terminal fragments of the mitochondrially encoded NADH 
dehydrogenase subunit 1 (35) were incubated with M3a-L a 
chimera-transfected cells (13S2) at 27~  overnight. N-formyl 
peptides as short as two amino acids significantly increased 
SMLF (4.2-fold; Fig. 1 C) compared with the solvent-treated 
cells (Fig.  1 A) or cells treated with N-formyl methionine 
(Fig. 1 B). The COOH-terminal addition of the third res- 
idue (phenylalanine) increased SMLF 6.5-fold. Moreover, the 
surface expression induced by the tetrameric (fMFFI; Fig. 1 
E), pentameric (fMFFIN; Fig. 1 F), hexameric (fMFFINI), 
and octameric (Fig. 1 H) peptides increased only slightly over 
this range (fold increases of 7.9,  8.2,  8.3,  and 8.0,  respec- 
tively). ~2-microglobulin was shown to be associated with 
these MHC  complexes by immunoprecipitation (data  not 
shown). Untransfected cells remained negative for staining 
(data not shown). 
Short N-Formyl Peptides Other  Than  ND1  Stabilized M3"- 
L d.  To test whether such binding was sequence specific, we 
assayed an expanded panel ofN-formyl peptides for their ability 
to  induce expression  of M3a-L a.  The N-formyl  dipeptide 
fMW induced the SMLF sixfold over controls at 27~  (Table 
I and Fig. 2). However, not all N-formyl peptides stabilized 
expression of the M3a-L a chimera. Two dipeptides, fMK and 
fMA, failed to induce M3a-L a (Table 1). The classical chemo- 
tactic tripeptide fMLF induced M3a-L a sevenfold. As with 
most other peptides that bind to M3 a, N-acetylated and un- 
substituted versions of the chemotactic peptide failed to stabi- 
lize the chimera. All N-formyl tripeptides tested except fMAS 
were active. Only one (fAGSE) of five N-formyl tetrapeptides 
tested failed to stabilize  M3a-L  a.  All short peptides tested 
that lacked an N-formyl group (n  =  11) failed to stabilize 
the chimera (listed in Materials and Methods; data not shown), 
indicating that the N-formyl moiety is required for the binding 
of such short peptides. 
fMLF-Benzyl Amide Stabilized the M3=-L  d Chimera at a Pep- 
tide Concentration As Low As 100 nM.  In crystal structures 
of class I molecules, the COOH terminus of the peptide forms 
H bonds and salt bridges with the heavy chain (3), suggesting 
specific interactions between peptide and heavy chain at this 
subsite. Peptides shorter than the canonical length cannot make 
significant interactions in both pockets A  and F. To deter- 
mine if the terminal carboxylate moiety is required for binding 
of very short peptides to M3 ~, the fMLF-benzyl amide com- 
pound was tested. This peptide analogue resembles the tetra- 
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Figure 1.  (A-H)  Very short N-formyl peptides derived from the NH2 terminus of fND1 stabilized  the expression of the MHC class I chimera M3a-L a 
on transfected fibroblasts.  Fluorescence of cells incubated with secondary antibody alone (- - -) or HB27 (  ) [anti-L d c~3]. Cells were incubated 
in 20 #M  of designated peptide overnight at  27~ 
1819  Vyas et al. Table  1.  Stabilization of H-2M3"L  d Surface Expression by Short 
N-Formyl Peptides 
Fold increase  Fold increase 
Sequence  •  SD  Sequence  •  SD 
fM  1.0  •  0.02 
fMW  5.9  •  0.3 
fMF  4.1  •  0.5 
fMV  3.7  •  0.3 
fMK  1.0  _  0.1 
fMA  1.2  •  0.2 
fMLF  7.3  _+  0.4 
AcMLF  1.3  •  0.1 
MLF  1.0  •  0.2 
t-Boc-MLF  1.0  •  0.1 
fMLF-oME  6.5  •  0.2 
fMLF-oBE  5.6  •  0.2 
fMLF-BeA  13.6  _+  0.7 
fMLY  3.8  •  0.2 
fMAS  0.9  •  0.1 
fZLF  3.6  •  0.2 
fMLFF  10.2  •  0.4 
fMFVL  8.7  •  0.4 
fMFFI  8.1  •  0.4 
fZLFK  3.3  •  0.1 
fMLFK  2.9  •  0.1 
fAGSE  1.3  •  0.3 
fMFVLN  8.1  •  0.5 
fMFFIN  8.4  •  0,5 
fMFFIN  I  8.6  +  0.4 
fMMM  5.3  _+  0.2  fMFFINILT  8.9  •  1.0 
fMFF  6.5  •  0.2  fMFVLNKFF  12.4  _  0.6 
fMFM  5.4  •  0.3  AcMFVLNKFF  1.0  •  0.02 
* 13S2 cells were incubated  in 20/~M of the indicted  peptide overnight 
at 27~  Numbers indicate the mean fold increase of three experiments 
_+  1 SD.  Fold increase was  calculated  as the SMLF of cells incubated 
with peptide divided by the SMLF of cells incubated in medium contain- 
ing DMSO alone.  SMLF in DMSO was 2.5,  2.5,  and  2.45  U  in the 
three experiments. 
f, N-formyl; Ac, N-acetyl; t-Boc,  t-Butyloxycarbonyl; Z, norleucine; MeE, 
methyl ester;  BeE, benzyl ester; BeA, benzyl amide. 
moved. Interestingly, the fMLF-benzyl amide compound was 
very active in its ability to upregulate cell surface expression 
of the M3~-L  a chimera. Increased surface expression was de- 
tected with this compound at concentrations as low as 100 
nM (Fig.  3).  Moreover, the dose curves of fMLFF, fMLF- 
benzyl amide, and fBla-zt-s  (fMFVLNKFF) virtually over- 
lapped, indicating that the components required for stable 
peptide binding are present in these short peptides. 
Peptide Length Affected the Rate of Disappearance of M3"-L a 
Chimera from  the Cell Surface.  The maximum surface ex- 
pression potential achieved by very short N-formyl ND1 pep- 
tides appeared to vary as a function of length. To determine 
if the length of the peptide bound affected the stability of 
HB27-reactive epitopes at the cell surface,  13S2 cells were 
incubated with DMSO (solvent with no peptide), fND11~, 
fNDll-5, or fNDlt-s at 27~  for 16 h to achieve surface ex- 
pression. Cells were then shifted to 37~  and the disappear- 
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Figure 2.  Average fold increase in M3'-L  d expression for different pep- 
tides as a function of peptide length. Data are from Table 1. O, N-formyl 
peptides; Vq, nonformylated peptides. The dark line indicates range of prob- 
able maximum induction for each length. 
4).  The half-life of the approach to a new steady state was 
estimated by nonlinear regression. The M3~-L  a chimera in- 
duced with the octameric peptide exhibited a half-life of 105 
min. Complexes induced with the shorter peptides were sub- 
stantially less stable in this assay. The complex with the pen- 
tapeptide was less stable at 37~  (tl/2  =  29 min) than the 
complex with the tetrapeptide (tl/2  --  62 min). These ob- 
servations were somewhat surprising because at 27~  the 
pentapeptide routinely induced more surface expression of 
M3~-L  a than did the tetrapeptide.  Chimeric molecules in- 
duced by cold temperature alone rapidly decayed from the 
cell surface at 37~  with a half-life of <15 min (Fig.  4). 
Short N-Formyl Peptide Binding Is Not an Artifact of the M3"- 
L d chimera.  To rule out the possibility that induction of 
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Figure 3.  Dose curve of selected short N-formyl peptides. Graded con- 
centrations of fMLF (~), tMLFF (1-3), fMLF-benzyl amide (0), and ~la- 
zl-s (A) were incubated  with  13S2 cells at 27~  overnight. 
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Figure 4.  Rate of M3~-L  a chimera decay was dependent  on the length 
of N-formyl peptide bound.  13S2 cells were incubated with fNDlt_8 (O), 
fND11_s (I-]), fND11-4 (O), and DMSO (solvent) (A) at 27~  overnight, 
shifted to 37~  for the indicated period of time, and stained with HB27. 
Nonlinear  regression analyses yielded estimates of tl/2 for complexes with 
each peptide: fNDll-4, 62 min, 95% confidence interval (CI), 56-69 min, 
r  2 =  0.99; fND11~s, 29 min, 95% CI, 28-31 min, r  2 =  0.99; fNDll-s, 
105 min, 95%  CI, 94-120  min, r  2 =  0.99. 
surface expression by short peptides might be an artifact of 
the M3"-L  a chimera, fMLF-benzyl amide was tested for its 
ability to bind competitively to native M3  ~ (Fig. 5). Target 
cells  expressing  M3 '  and  an  alternative  allele  of  fND1 
(fND1 ~) cannot be lysed by M3~-restricted,  NDl'*-specific 
CTLs. However, incubation of the fND1%12 peptide renders 
these cells susceptible to lysis by these CTLs. When graded 
amounts of the putative competitor peptide fMLF-benzyl 
amide were added to sensitized targets, marked reduction of 
lysis was noted, indicating that the short competitor peptide 
bound to M3 ~. The fBla-zl-8 peptide also inhibited specific 
lysis and served as a positive control, whereas the AcBla-zl-s 
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Figure 5.  N-formyl MLF-benzyl amide competitively binds native M3~. 
Competition by fMLF-benzyl  amide (e), fBla-zl-s (F']), and AcBla-zl-s 
(O) of lysis by M3a-restricted  NDl~-specific CTLs using WEHI 105.7 
NZB thymoma cells (H-2  a, M3  a, NDlO) as target  cells. 
peptide failed to inhibit specific lysis and served as a negative 
control. These data demonstrate that short peptide binding 
to M3a-L  d emulates that of the native M3 ~. 
Short Peptide Binding Is Not a Common Property of MHC 
Class I-a Molecules.  To test whether MHC class I-a mole- 
cules can bind segments of active peptides, NH2-terminal 
(SIIN and SIINF) and COOH-terminal fragments (NFEKL) 
of the Kb-restricted  ovalbumin peptide (SIINFEKL)  (29) 
were incubated with RMA-S cells overnight. The COOH- 
terminal fragment was included in this panel because it re- 
tained both major anchor residues (N, L) for peptide binding 
to K b. As expected, SIINFEKL but not the short peptides 
stabilized  K  b,  as detected by mAbs TIB  139  and HB176 
(Y3)  (Fig.  6).  Similarly,  the  Sendai  virus  nucleoprotein 
nonapeptide (FAPGNYPAL) (30) but not the NH2-terminal 
(FAPGN) or COOH-terminal (NYPAL) fragments stabilized 
K b and D b. These data suggest that NH2 and COOH ter- 
mini for these peptides must be near pockets A  and F for 
stable binding. These results confirm the concept that stable 
binding of short peptides is not a general feature of class I 
molecules. 
Discussion 
Graphical representation of the data shown in Table I sug- 
gest that maximal surface expression can be induced by pep- 
tides in the range of three to four amino acids (Fig. 2). We 
cannot  so  far  rule  out  the  possibility that  an N-formyl 
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Figure 6.  H-2K  b and  H-2D  b molecules do not bind short  peptides. 
RMA-S cells were incubated  in 20 pM peptide  overnight at 37~  and 
analyzed with mAb TIB 139 (anti-K  b, white), mAb HB 176 (Y3) (anti- 
K b, black),  and mAb HB19 (anti-D  b, hatched). 
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larly, we cannot yet exclude the hypothesis that peptides other 
than those tested can induce surface expression more than 
suggested by the plateau of the dark line in Fig.  2. Despite 
these caveats,  our working model is that elements present 
in  short  peptides  (no  longer  than  four  amino  acids)  are 
sufficient for maximum induction of surface expression. In 
addition, longer peptides that deviate downward from the 
dark line in Fig.  2 may reflect the presence of destabilizing 
side chains rather than the absence of anchoring residues. 
Destabilizing or "dominant negative" (36) peptide side chains 
have been observed for other class  I  molecules, including 
H-2K  b (37), H-2K  a (38), HLA-A2 (39, 40), and for the class 
II molecule H-2E  k (36). 
The ability of M3  ~ to bind short peptides further differen- 
tiates this I-b molecule functionally from the model estab- 
lished for other class I molecules. The most dramatic differ- 
ence remains the requirement for the N-formyl moiety (18, 
21). The results presented here suggest that the free energy 
of binding to M3 ~ derives mostly from interactions with the 
N-formyl group and the first several peptide bonds. We pre- 
viously showed that glycine in P1 can relax the requirement 
for the N-formyl moiety (19). In addition, the inactivity of 
all tested dipeptides with glycine or alanine in P2 suggests 
that the R  group of P2 interacts at least  weakly with the 
MHC heavy chain (Fig.  7). In contrast, peptide binding to 
MHC class I-a molecules involves multiple side chains in ad- 
dition to both termini and the backbone. 
The remarkable ability of this MHC class I-b molecule 
to bind short peptides suggests that the antigen-binding cleft 
of M3 ~ may be quite different from those found in MHC 
M3 a 
Figure 7.  Model  representing  peptide binding to  K b (top) and M3  ~ 
(bottom). Peptides of eight to nine amino acids in length fit into the antigen- 
binding groove of K  b. These peptides possess the appropriate binding 
motif at P5 and P9. Moreover, the peptide termini engage deep pockets 
and anchor the peptide in this position.  In contrast,  M3 ~  binds N-formyl 
peptides of heterogenous lengths by interacting directly with the N-formyl 
moiety. For short peptides, the COOH terminus does not interact with 
heavy chain residues in pocket F. For M3~, the contribution of P2 may 
be important. 
class I-a molecules. A model comparing the peptide interac- 
tion with the prototypical MHC class I-a molecule K b and 
the MHC class I-b molecule M3 ￿9 is depicted in Fig.  7. K b- 
binding peptides must be eight or nine residues long for their 
termini to anchor into the conserved residues of the cleft. 
Additionally, Kb-binding peptides must possess  particular 
amino acids at P5 (Tyr or Phe) and P9 (Leu) to bind stably 
in this cleft. Although the data indicate that K b and D b are 
incapable of binding short peptides, we do not imply that 
all other MHC class I  molecules lack this ability.  Indeed, 
it would be of interest to determine whether other MHC 
class I molecules, especially I-b molecules, may bind short 
peptides. 
H-2K  b appears prototypical among class I-a molecules to 
date. Saito  et al.  (37) have argued that optimal binding to 
H-2K  b actually involves proper fit of all side chains of the 
peptide in addition to the dominant anchors. Similarly, based 
on extensive kinetic analyses ofpeptide dissociation from HLA- 
A2, Parker et al. (39) have advanced a quantitative indepen- 
dent binding of sidechains (IBS) model of peptide binding 
in which each side chain contributes additively (and indepen- 
dently) to the free energy of binding, even though the mag- 
nitude of each contribution may vary. In addition,  their model 
presupposes a constant additive contribution from the pep- 
tide backbone and the termini. In applying the IBS model 
to M3  a, it appears that the N-formyl moiety and perhaps the 
first several  peptide linkages contribute the majority of  binding 
energy. Additionally, data presented in this report support 
that  notion  that  large  hydrophobic  amino  acids  such  as 
phenylalanine or tryptophan are optimal residues for occupancy 
at P2. The additional residues of longer peptides may be re- 
stricted to hydrophobic amino acids because of the hydro- 
phobic nature of the antigen-binding groove of M3 ~. 
Steady-state  and  kinetic  analyses  of fND1  peptides  of 
different lengths suggest that distal elements of the peptide 
can affect binding affinity and/or the conformation of the 
complex if upstream elements are not optimal. Because the 
natural length of fND1 is not known, a synthetic octamer 
was used as a surrogate. Compared with the shorter analogues, 
fNDll-s induced a slightly higher steady state level of M3 a- 
L d at  27~  that  was  also  significantly more  stable  after 
shifting to 37~  Thus, the average fold induction increased 
uniformly for peptides of the fND1 series (octamer sequence 
flVlFFINILT), from 4.1-fold for the dimer to 8.9-fold for the 
octamer (see Table 1). The tetramer and pentamer peptides 
exhibited intermediate fold inductions of 8.1- and 8.4-fold. 
A much larger relative effect on the rate of decay at 37~ 
was measured in the temperature shift experiment, in which 
the  tl/2  of the octamer-containing complex was  105  rain 
compared with 62 and 29 rain for complexes containing the 
tetramer and pentarner peptides, respectively.  The apparent 
discrepancy that complexes with the tetrapeptide are longer 
lived than complexes with the pentapeptide may suggest that 
the asparagine in P5 either increases the dissociation rate con- 
stant for the peptide-heavy chain complex, or that it induces 
a conformational change in the complex that renders it less 
stable. Both of these models are consistent with the concept 
of "dominant negative" side chain interactions. 
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may account for the increase in the apparent half-life of the 
M3~-L  a heavy chain epitopes when these cells were shifted 
to 37~  By occupying more of the heavy chain cleft, longer 
peptides might make a larger number of favorable contacts, 
resulting in a net decrease in the rate of dissociation of the 
peptide from the binding cleft. Alternatively (but not mutu- 
ally exclusively),  these data could mean that complexes of 
M3~-L  a containing different peptides may exhibit different 
intrinsic decay rates.  In this view, different peptides induce 
distinct conformations. Differentiating these models will re- 
quire direct measurements of koff. 
Since short peptides might establish a reduced number of 
direct contacts with TCR residues,  positive selection of de- 
veloping thymocytes by short peptides might involve allosteric 
or conformational effects on the heavy chain. Thus, TCR 
of M3a-restricted CTL may focus on the heavy chain rather 
than on peptide side chains. Support for this idea comes from 
crystallographic analyses of K b and HLA-A2 molecules as- 
sociated with peptides. These studies suggest that peptide 
binding induces small but discrete changes in the orientation 
of heavy chain residues (induced fit) (3, 41).  Alternatively, 
TCR may interact with M3 a asymmetrically such that most 
of the binding energy is provided by contacts close to pocket 
A, a feature seen in some T cells allospecific for HLA-B27 (42). 
A conservative model of class Ib function assumes that the 
rules governing positive and negative selection of responsive 
T  cells are similar to those governing T  cells restricted by 
class Ia molecules. Assuming that M3 a does play a protec- 
tive role, one problem posed when this hypothesis is applied 
to M3  a and other class I-b  molecules that bind a narrow 
specificity  of peptides is how a suitable repertoire of TCR 
may be positively selected. Thus, recent evidence suggests 
that self-peptides are required for positive selection of thymo- 
cytes (43, 44) and that peripheral T cells react with only those 
foreign peptides that closely resemble self-peptides. This model 
imposes an extraordinary limitation on M3 a since mitochon- 
dria encode only 13 proteins (45). Violating the size rule may 
increase the repertoire of thymic peptides available for posi- 
tive selection. On the other hand, it remains possible that 
positive selection of T  cells restricted by M3  a does not de- 
pend on engagement by the TCR of particular peptides, but 
rather on the mere presence of M3 a at the cell surface.  In 
this view, the limited availability  of endogenous mitochon- 
drial N-formyl peptides available for promoting surface ex- 
pression of M3 '  (21) would limit the quantity but not the 
complexity of the repertoire of T  cells restricted by M3  ~. 
Alternatively, one might surmise from the paucity of ob- 
vious thymic-selecting peptides that T cells restricted by M3  ' 
are positively selected in an extrathymic environment that 
has access to N-formyl peptides. One such environment could 
be Peyer's patches or similar intestinal sites in which N-formyl 
peptides from normal microbial flora might be available for 
positive selection. In this regard, it is interesting to note that 
the non-MHC-encoded class I-b molecule CD1 is expressed 
in the intestinal epithelia in the absence of either TAP trans- 
porter or 32-microglobulin function (46, 47).  Similarly,  the 
MHC-linked class I-b molecule Tla is expressed at high levels 
by intestinal epithelial cells, where it may present ligands to 
resident "y8 T  cells (48). 
MHC class I-a molecules present a relatively broad reper- 
toire of peptides to T cells during thymic education and an- 
tigen recognition. By analogy to species occupying broad eco- 
logical niches (49),  we have termed such MHC molecules 
eurytopic (50).  In contrast, M3 a is stenotopic, not strictly 
because of the limited repertoire of peptides it can present, 
but because it apparently targets a specialized  niche in the 
economy of the immune system. Stenotopic MHC genes may 
evolve rapidly by gene duplication but with minimal poly- 
morphism (50).  Relaxation of the length rule for M3' is 
consistent with the evolution of a gene under selection pres- 
sure to maximize restriction of bacterial peptides within the 
confines of the N-formyl niche. Alternatively, if self-peptides 
are required for positive selection of M3~-restricted T  cells, 
it is possible  that the violation of the length rule by M3 a 
was a necessary preadaptation required before evolution of 
an N-formyl pocket was possible. 
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